Submit Manuscript
Chat with us
Toggle navigation
Home
About
Open Access
Articles
Journals
Guidelines
Editors
Editor Guidelines
Join as Editor
Associate Editor
Associate Editor Guidelines
Join as Associate Editor
Author
Author Guidelines
Peer Review Process
Manuscript Guidelines
Processing Fee
Pay Online
Reprints
Reviewer
Reviewer Guidelines
Policies
Plagiarism Policy
Ethics Policy
Terms and Conditions
Cancellation and Refund Policy
Shipping and Delivery Policy
Contact Us
ebooks
Submit Manuscript
Advanced Nursing & Patient Care International Journal
ISSN: 2642-0147
Editorial
Reflections on the Performance of the Pharmacovigilance Programme of India for the Year 2022-2023
Authors:
Singh KK*, Sahoo S, Raghuvanshi RS
Show Affiliations
×
Author Affiliations
Singh KK*
Indian Pharmacopoeia Commission, Ministry of Health and Family Welfare, India
Email:
kksingh.ipc@gov.in
Sahoo S
Indian Pharmacopoeia Commission, Ministry of Health and Family Welfare, India
Raghuvanshi RS
Indian Pharmacopoeia Commission, Ministry of Health and Family Welfare, India
Published:
2024-11-10
PDF:
View
Abstract
The performance report of the Pharmacovigilance Programme of India (PvPI) for the year 2022-2023 underscores the nation’s assiduous commitment to patient safety through comprehensive drug and medical device safety monitoring [1].
« Previous: Angle Determination in ECG Using Trigonometric Formula
Next: Dietary Pattern and Onset of Menarche among High School Students - A Correlational Study »